TrialSignal
Clinical trial intelligence report
Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT02679287
Status
COMPLETED
Phase
NA
Sponsor
University of Virginia
Executive brief
Investment-Ready Snapshot
The trial evaluated the efficacy of a Closed-Loop Control (CLC) system for managing blood glucose levels in individuals with Type 1 Diabetes. The study compared different configurations of the CLC system against standard sensor-augmented pump therapy, focusing on user acceptance and clinical outcomes.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02679287
Indication
Diabetes Mellitus, Type 1
Modality
medical device
Target
Type 1 Diabetes Mellitus
Intervention
CLC
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.